This novel, minimally invasive,
device is a shunting system for the diversion of cerebrospinal fluid (CSF) that
does not use catheters or tubing. This catheterless system provides direct CSF
diversion out of the central nervous system, dramatically decreasing revision
rate since catheter clogging remains the most common reason for failure.
This invention relates to the
treatment of hydrocephalus or for pressure relief secondary to trapped fluid in
any body cavity. Hydrocephalus alone accounts for over 40,000 operations
performed annually in the US. Medical costs for hydrocephalus are estimated to
be over $1 billion per year.
This invention will allow for an
effective and less invasive treatment of communicating hydrocephalus with better
long-term outcomes and reduced incidence of infection. The technology will also
help treat trapped fluids in other parts of the body such as ascites or pleural